249 related articles for article (PubMed ID: 401681)
1. Destruction of experimental malignant melanoma by mediators of cellular immunity.
Youdim S
Cancer Res; 1977 Feb; 37(2):572-7. PubMed ID: 401681
[TBL] [Abstract][Full Text] [Related]
2. Resistance to tumor growth mediated by Listeria monocytogenes. Destruction of experimental malignant melanoma by LM-activated peritoneal and lymphoid cells.
Youdim S
J Immunol; 1976 Mar; 116(3):579-84. PubMed ID: 56396
[TBL] [Abstract][Full Text] [Related]
3. Resistance to tumor growth mediated by Listeria monocytogenes: collaborative and suppressive macrophage-lymphocyte interactions in vitro.
Youdim S; Sharman M
J Immunol; 1976 Nov; 117(5 Pt.2):1860-5. PubMed ID: 825574
[TBL] [Abstract][Full Text] [Related]
4. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
Gordon WC; Prager MD
Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
[TBL] [Abstract][Full Text] [Related]
5. Generation of alloreactive cytotoxic T lymphocytes: production of T cell and macrophage helper factors in addition to IL 1 and IL 2 by peritoneal cells from mice immunized to Listeria monocytogenes.
Finke JH; Sharma SD; Scott JW
J Immunol; 1981 Dec; 127(6):2354-61. PubMed ID: 6795272
[TBL] [Abstract][Full Text] [Related]
6. Effect of tumor cells on the generation of cytotoxic T lymphocytes in vitro. I. Accessory cell functions of mouse tumor cells in the generation of cytotoxic T lymphocytes in vitro: replacement of adherent phagocytic cells by tumor cells or 2-mercaptoethanol.
Koren HS; Hodes RJ
Eur J Immunol; 1977 Jun; 7(6):394-400. PubMed ID: 302208
[TBL] [Abstract][Full Text] [Related]
7. In vitro induction of polyclonal killer T cells with 2-mercaptoethanol and the essential role of macrophages in this process.
Igarashi T; Okada M; Kishimoto T; Yamamura Y
J Immunol; 1977 May; 118(5):1697-703. PubMed ID: 67145
[TBL] [Abstract][Full Text] [Related]
8. Cooperation of immune lymphoid and reticuloendothelial cells during Listeria monocytogenes-mediated tumor immunity.
Youdim
Cancer Res; 1977 Apr; 37(4):991-6. PubMed ID: 403003
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity mediated by soluble macrophage product(s).
Sethi KK; Brandis H
J Natl Cancer Inst; 1975 Aug; 55(2):393-5. PubMed ID: 808640
[TBL] [Abstract][Full Text] [Related]
10. Synergy between subpopulations of normal mouse spleen cells in the in vitro generation of cell-mediated cytotoxicity specific for "modified self" antigens.
Hodes RJ; Hathcock KS; Shearer GM
J Immunol; 1975 Oct; 115(4):1122-5. PubMed ID: 51877
[TBL] [Abstract][Full Text] [Related]
11. Specificities of killing by cytotoxic lymphocytes generated in vivo and in vitro to syngeneic SV40 transformed cells.
Gooding LR
J Immunol; 1977 Mar; 118(3):920-7. PubMed ID: 191529
[TBL] [Abstract][Full Text] [Related]
12. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression.
Ting CC; Rodrigues D
J Natl Cancer Inst; 1982 Oct; 69(4):867-72. PubMed ID: 6214653
[TBL] [Abstract][Full Text] [Related]
13. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
14. Significance of suppressor macrophages for immunosurveillance of tumor-bearing mice.
Fujii T; Igarashi T; Kishimoto S
J Natl Cancer Inst; 1987 Mar; 78(3):509-17. PubMed ID: 2950265
[TBL] [Abstract][Full Text] [Related]
15. Reversal by peritoneal adherent cells of tumor cell suppression of T cell-mediated immunity.
Ting CC; Rodrigues D
J Immunol; 1979 Aug; 123(2):801-7. PubMed ID: 156764
[No Abstract] [Full Text] [Related]
16. Suppression of in vitro maintenance and interferon-mediated augmentation of natural killer cell activity by adherent peritoneal cells from normal mice.
Brunda MJ; Taramelli D; Holden HT; Varesio L
J Immunol; 1983 Apr; 130(4):1974-9. PubMed ID: 6187831
[TBL] [Abstract][Full Text] [Related]
17. Studies of the mechanisms for the induction of in vivo tumor immunity. IV. Enhancement of the in vitro generation of secondary cell-mediated cytotoxic response by normal peritoneal macrophages and their culture supernatants.
Igarashi T; Rodrigues D; Ting CC
J Immunol; 1979 Apr; 122(4):1519-27. PubMed ID: 156217
[TBL] [Abstract][Full Text] [Related]
18. Sensitization of T lymphocytes in vitro by syngeneic macrophages fed with tumor antigens.
Treves AJ; Schechter B; Cohen IR; Feldman M
J Immunol; 1976 Apr; 116(4):1059-64. PubMed ID: 1082902
[TBL] [Abstract][Full Text] [Related]
19. Generation of cytotoxic T lymphocytes during coxsackievirus tb-3 infection. II. Characterization of effector cells and demonstration cytotoxicity against viral-infected myofibers1.
Wong CY; Woodruff JJ; Woodruff JF
J Immunol; 1977 Apr; 118(4):1165-9. PubMed ID: 300400
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of carrier-mediated transport after immunologic activation of peritoneal macrophages.
Bonventre PF; Straus D; Baughn RE; Imhoff J
J Immunol; 1977 May; 118(5):1827-35. PubMed ID: 404359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
